AMY MEADORS: Open Payments
NPI 1508207226 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 40 payments from 16 companies in 2025. Trend: 2023 $648 · 2024 $828 · 2025 $1,251
Food & beverage: $1,152Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $178 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $175 |
| GENZYME CORPORATION | 3 | $154 |
| ABBVIE INC. | 9 | $152 |
| AstraZeneca Pharmaceuticals LP | 3 | $147 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| BioCryst US Sales Co., LLC | 1 | $74 |
| Inspire Medical Systems, Inc. | 1 | $66 |
| ALK-Abello, Inc | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
Products named: DUPIXENT, NEFFY, QULIPTA, AIRSUPRA, NUCALA, ORLADEYO, INSPIRE, ELAPRASE.
Industry payments across VA — which companies pay providers there.
